Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.
The early transcription unit 3 (E3) of human adenoviruses (Ads) encodes proteins with various immunomodulatory functions. Ads from different subgenera differ considerably in their E3 coding capacity, suggesting that distinct sets of immunomodulatory E3 proteins may influence the disease pattern associated with different Ad subgenera. Interestingly, the E3 region of Ads classified in subgenus D, which are often isolated from AIDS patients and have the propensity to cause eye infections, contains a unique gene, named E3/49K, that may encode a protein with a calculated molecular weight of 48,984 that might be implicated in diseases caused by this subgenus. The 49K sequence predicts a highly glycosylated type I transmembrane protein with a short cytoplasmic tail containing two motifs, YXXPhi and LL, potentially involved in targeting the protein to endosomal or lysosomal compartments. Remarkably, the 49K protein is predicted to contain an unusual immunoglobulin-like fold. Here we have characterized the E3/49K protein of Ad type 19a, an Ad of subgenus D which causes epidemic keratoconjunctivitis. E3/49K was synthesized as an 80- to 100-kDa protein, which is unusually large for an E3 protein. In contrast to another early protein, E3/19K, the expression of E3/49K started early but continued throughout the infection cycle. Analysis of the 49K glycosylation revealed that the majority of 49K molecules contained only 12 of the predicted 14 N-glycans. Furthermore, we provide evidence that 49K is O-glycosylated. At steady state, E3/49K was localized in the Golgi-trans-Golgi network and in early endosomes. Interestingly, the 49K protein has a rather short half-life and seems to be proteolytically cleaved. A processing pattern similar to that in the early stages of infection is seen in transfected cells, constitutively expressing 49K in the absence of other Ad proteins. Together, our data provide the first biochemical and cell biological characterization of an unique E3 protein of subgenus D Ads.
Windheim
Mark
M
Max-von-Pettenkofer Institute, Gene Center, Ludwig-Maximilians-University, 81377 Munich, Germany.
Burgert
Hans-Gerhard
HG
D017503:Adenovirus E3 Proteins / Q000096:biosynthesis / Q000737:chemistry* / Q000378:metabolism*; D000260:Adenoviruses, Human / Q000737:chemistry* / Q000502:physiology; D000595:Amino Acid Sequence; D002478:Cells, Cultured; D003001:Cloning, Molecular; D003236:Conjunctivitis, Viral / Q000821:virology*; D004220:Disulfides / Q000378:metabolism; D011992:Endosomes / Q000378:metabolism / Q000821:virology; D005347:Fibroblasts; D006031:Glycosylation; D006801:Humans; D008358:Mannose / Q000032:analysis; D008969:Molecular Sequence Data; D008970:Molecular Weight; D011134:Polysaccharides / Q000032:analysis; D011499:Protein Processing, Post-Translational; D014407:Tumor Cells, Cultured; D021601:trans-Golgi Network / Q000378:metabolism / Q000821:virology
D017503:Adenovirus E3 Proteins; D004220:Disulfides; D011134:Polysaccharides; D008358:Mannose